| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 09/19/2002 | CA2341998A1 Anti-emetic, anti-motion sustained release drug delivery system, |
| 09/18/2002 | WO2001072285A1 Easy-to-take granule |
| 09/18/2002 | EP1241226A1 Use of a polyol as a gelling agent for cold-water soluble gelatin gels. Films, articles and capsules formed therefrom |
| 09/18/2002 | EP1241134A2 Inhomogeneous silica as support |
| 09/18/2002 | EP1241113A1 Inhaler with means for improving chemical stability of medicinal aerosol solution contained therein |
| 09/18/2002 | EP1240897A1 Pharmaceutical tablet and process for making thereof |
| 09/18/2002 | EP1240896A2 Encapsulation of water soluble peptides |
| 09/18/2002 | EP1240887A1 An aerosol device including a hair-treatment composition having a polysaccharide grafted by a polysiloxane |
| 09/18/2002 | EP1240883A1 Method for manufacturing seamless capsule |
| 09/18/2002 | EP1240355A1 Removal of dye-labeled dideoxy terminators from dna sequencing reactions |
| 09/18/2002 | EP1240343A2 Nucleic acid vaccine compositions having a mammalian cd80/cd86 gene promoter driving antigen expression |
| 09/18/2002 | EP1240261A1 Medicament delivery device with moisture resistant coating |
| 09/18/2002 | EP1240230A1 Swelling and deswelling polymer blends |
| 09/18/2002 | EP1240212A1 Crosslinked copolymers based on non-crosslinked polycarboxylic copolymers |
| 09/18/2002 | EP1240193A2 Peptide fragments of colostrinin |
| 09/18/2002 | EP1240157A2 Substituted n-benzyl-indol-3-yl glyoxylic acid derivatives having an anti-tumoral effect |
| 09/18/2002 | EP1240136A1 Use of biologically active vitamin d compounds for the prevention and treatment of inflammatory bowel disease |
| 09/18/2002 | EP1239938A1 Method for capturing fine particles by percolation in a bed of granules |
| 09/18/2002 | EP1239898A2 Implant device for implanting cell culture |
| 09/18/2002 | EP1239884A2 Methods for preparing pharmaceutical formulations |
| 09/18/2002 | EP1239873A2 Method for localized administration of fibrinolytic metalloproteinases |
| 09/18/2002 | EP1239872A2 Enzyme treatment for infection |
| 09/18/2002 | EP1239865A1 Pharmaceutical composition for preventing and treating erectile impotence using purified sumsoo extract |
| 09/18/2002 | EP1239857A1 Dual-release compositions of a cyclooxygenase-2- inhibitor |
| 09/18/2002 | EP1239856A1 Sustained-release formulation of a cyclooxygenase-2 inhibitor |
| 09/18/2002 | EP1239849A2 Pharmaceutical formulations comprising resveratrol and use thereof |
| 09/18/2002 | EP1239847A1 Flat medicinal preparation for transmucosal administration of oxycodon or a comparable active ingredient in the oral cavity, for use in pain therapy and in addiction therapy |
| 09/18/2002 | EP1239846A2 Transdermal administration of phenylpropanolamine |
| 09/18/2002 | EP1239845A2 Hydroxide-releasing agents as skin permeation enhancers |
| 09/18/2002 | EP1239844A1 Process for producing nanometer particles by fluid bed spray-drying |
| 09/18/2002 | EP1239843A1 New (aminopropyl)methylphosphinic acids |
| 09/18/2002 | EP1239842A1 Electrostatic application of powder material to solid dosage forms |
| 09/18/2002 | EP1239841A1 Pharmaceutical formulations comprising sodium amoxycilline and potassium clavulanate |
| 09/18/2002 | EP1239840A2 Antiviral medication |
| 09/18/2002 | EP1239839A2 Hydrogel-driven layered drug dosage form comprising sertraline |
| 09/18/2002 | EP1239838A2 Method for tabletting thickening systems |
| 09/18/2002 | EP1239837A2 Direct compression polymer tablet core |
| 09/18/2002 | EP1239836A1 Colloidal suspension of submicronic particles as vectors for active principles and method for preparing same |
| 09/18/2002 | EP1239835A1 Pharmaceutical compositions providing enhanced drug concentrations |
| 09/18/2002 | EP1239834A2 Mixed structures resulting from the incorporation of a biological macromolecule, especially of dna, in a liquid crystal phase of amphiphiles, and vesicles obtained using these structures |
| 09/18/2002 | EP1239833A2 Reconstitution of purified membrane proteins into preformed liposomes |
| 09/18/2002 | EP1239832A2 Suspension comprising oxcarbazepine |
| 09/18/2002 | EP1239831A1 Improved pharmaceutical compositions for poorly soluble drugs |
| 09/18/2002 | EP1239830A2 Dosage forms having a barrier layer to laser ablation |
| 09/18/2002 | EP1239829A1 Devices for the delivery of drugs having antiprogestinic properties |
| 09/18/2002 | EP1239826A2 Cosmetic and/or pharmaceutical preparations |
| 09/18/2002 | EP1239769A2 Ingestible device for the release of substances at distinct locations in the alimentary canal |
| 09/18/2002 | EP1239765A1 Ingestible device for the release of substances at distinct locations in the alimentary canal |
| 09/18/2002 | EP0952837B1 Use of mixtures of active substances, containing phytostenols and/or phytostenol esters and potentiators, for the production of hypocholesteremic agents |
| 09/18/2002 | EP0949912B1 Method for preparing a multi-particulate pharmaceutical form with controlled multi-sequential release |
| 09/18/2002 | EP0921808B1 Non-aqueous polar aprotic peptide formulations |
| 09/18/2002 | EP0915684A4 Material for buffered resorbable internal fixation devices and method for making same |
| 09/18/2002 | EP0877591B1 Hair conditioning compositions |
| 09/18/2002 | EP0861096B1 Water soluble films |
| 09/18/2002 | EP0810880B1 Pharmaceuticals and assays using enzyme subunits |
| 09/18/2002 | EP0724432B1 Methods and compositions for microencapsulation of antigens for use as vaccines |
| 09/18/2002 | CN1370237A Recombinant parainfluenza virus vaccines attenuated by deletion or ablation of non-essential gene |
| 09/18/2002 | CN1370232A Methods for making APO-2 ligand using divalent metal ions |
| 09/18/2002 | CN1370201A Polymeric compsn. for solubilizing poorly water soluble drugs and process for prepn. thereof |
| 09/18/2002 | CN1370195A Rapidly decomposing chitosan-based pellets |
| 09/18/2002 | CN1370181A Effectors of dipeptidyl peptidase IV for topical use |
| 09/18/2002 | CN1370083A Ninovasive genetic immnization, expression products therefrom, and uses thereof |
| 09/18/2002 | CN1370081A Synergistic combination |
| 09/18/2002 | CN1370072A Sulfoalkyl ether cyclodextrin based controlled release solid pharmaceutical formulations |
| 09/18/2002 | CN1370070A Carnitine analogues as topical, microbicidal spermicides |
| 09/18/2002 | CN1370068A Pharmaceutical agent comprising benzamide derivative as active ingredient |
| 09/18/2002 | CN1370065A Pharmaceutical prepn. |
| 09/18/2002 | CN1369556A Liposome encapsulated baccatin III derivative and its usage |
| 09/18/2002 | CN1369310A Coating agent for treating tinea and eczema |
| 09/18/2002 | CN1369308A Liniment 'Rubikang' and its preparing process |
| 09/18/2002 | CN1369302A Solid essential balm |
| 09/18/2002 | CN1369294A Liniment for repairing scratched face without residual scar |
| 09/18/2002 | CN1369293A Chinese-medicinal ointment for treating burn and scald and its preparing process |
| 09/18/2002 | CN1369287A 'Shuanghuang Yupi' cream for skin healing |
| 09/18/2002 | CN1369277A Exterior-applied plaster for treating lumbar vertebra disease, cervical vertebra disease and osteoarthropathy and its preparing process |
| 09/18/2002 | CN1369269A Nano silver antibacterial film for women its preparing method and use |
| 09/18/2002 | CN1369264A Concentrated Chinese medicine particles and application thereof |
| 09/18/2002 | CN1369263A Flexible vitaminc A acid liposome and its product |
| 09/18/2002 | CN1369202A Dosinfecting nano active microcapsule for military material use for civil purpose now |
| 09/18/2002 | CN1090964C Powered medicine for treating liver cancer, gastric cancer, lung cancer and esophags cancer |
| 09/18/2002 | CN1090963C Fast-acting nemostatic pellet |
| 09/18/2002 | CN1090962C Ointment for burn |
| 09/18/2002 | CN1090961C Process for preparing onychomycosis ointment |
| 09/18/2002 | CN1090960C Process for preparing onychomycosis liquid |
| 09/18/2002 | CN1090957C Navel plaster for treating stomach diseases |
| 09/18/2002 | CN1090956C Tibetan pill for treating cholecytitis and gallstones, and method for preparing same |
| 09/18/2002 | CN1090949C Tongmai shulou vessel-freeing injection and its preparing tech |
| 09/18/2002 | CN1090947C External application powder compsn. and cloth wetting agent |
| 09/18/2002 | CN1090943C Easy-to-store and-use compound royal jelly and its preparing method |
| 09/18/2002 | CN1090935C Pharmaceutical compsn. of piperidnoalkanol compounds |
| 09/18/2002 | CN1090934C Prepn. of salts of pharmaceutical active substances which have acidic groups |
| 09/18/2002 | CN1090932C External-use ointment for face and its preparing process |
| 09/18/2002 | CN1090916C Oral liquid for preventing altitude disease and its preparing process |
| 09/18/2002 | CA2403594A1 Granules having good taking property |
| 09/17/2002 | US6452133 Apparatus and methods for alternating laser treatment of pharmaceutical dispensers |
| 09/17/2002 | US6451860 Methods for treating depression and other disorders using optically pure (−)-bupropion |
| 09/17/2002 | US6451848 Compositions and methods comprising morphine gluconate |
| 09/17/2002 | US6451779 Composition and method for contraception and treatment of tumors of the mammary glands |
| 09/17/2002 | US6451773 Composition for treating acneiform eruption containing: (a) a chitosan having a molecular weight ranging from about 500,000 to about 5,000,000 g/mole and a degree of deacylation greater than 80%; (b) an acid-form active ingredient for treating acne |
| 09/17/2002 | US6451772 Biopolymer salts with low endotoxin levels, biopolymer compositions thereof and methods of making the same |